Thursday, December 1, 2022
HomeCovid-19Japan Study Finds Effective Treatment for Severe COVID-19 Patients

Japan Study Finds Effective Treatment for Severe COVID-19 Patients

As scientists around the world are in the race to develop an effective vaccine against Covid-19, a group of Japanese scientists has tested a drug to treat severe COVID-19 patients.

The research team has found the drug effectively blocks the activity of a protein component, interleukin-6 (IL-6), known to be elevated in many severe Covid-19 patients. The findings are first published in a scientific journal PNAS on August 21, 2020 (Kang et al., 2020).

In response to infection, trauma, or diseases like cancer, our body produces a kind of smaller protein molecules, known as cytokines that stimulate the inflammatory process to heal the body. The problem is if overstimulation occurs, the cytokines become harmful, leading to many complications, from asthma to severe autoimmune diseases.

Increased Level of Cytokines in Covid-19 Cases

Cytokine release syndrome (CRS) is one such complication that develops in patients suffering a hyperactive immune response due to infection or trauma and can result in multiple organ failures, even death.

“Despite knowing which cytokines are involved, there is still no specific immunotherapy for CRS, and treatment is limited to supportive care,” stated study lead author Sujin Kang at Immunology Frontier Research Center, Osaka University in Japan.

The authors of the report first investigated cytokine profiles of 91 patients diagnosed with CRS associated with bacterial infection, respiratory distress, or burns.

They observed increased levels of cytokines IL-6, IL-8, IL-10, and MCP-10, as well as a protein called PAI-1, which causes small blood clots in vessels throughout the body, including the lungs, in patients from all three groups.

Commonly, increased PAI-1 levels are associated with more severe cases of pneumonia, a known cause of death among Covid-19 patients.

IL-6 signaling blockade Useful for Covid-19 Treatment

severe covid-19

Since IL-6 was positively related to the levels of other cytokines and PAI-1, the researchers concluded that IL-6 signaling is crucial for the development of CRS following infection or trauma, and may play a role in the pathogenesis of Covid-19.

Then the researchers recruited seven patients with severe-to-critical Covid-19. They intravenously injected tocilizumab, a human monoclonal antibody-based drug known as Actemra®.

The researchers found that all seven patients exhibited decreased serum PAI-1 levels and improved clinical features, including lower C-reactive protein (CRP) levels.

IL-6 signaling blockade could therefore prove useful for the treatment of both CRS and the severe respiratory complications of COVID-19, the research team noted.

Related Publication and Further Readings

Kang, S., T. Tanaka, et al. (2020). “IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.” Proc Natl Acad Sci U S A 117(36): 22351-22356.

Recent Post



Social Connection as the Strongest Protective Factor for Depression—New Study Identifies

Active social connection is the most influential protective factor for depression, Additionally, reducing sedentary activities such as watching TV or taking a nap can also help lower depression risk.


Regardless Of the Therapeutic Impact, Cannabis Studies Have Received Favorable Media Attention

Cannabis studies attract media attention independent of clinical outcome, report Karolinska Institutet researchers.

Avocados Change Belly Fat Distribution in Women

An avocado a day could help redistribute belly fat in women toward a healthier profile, reports a new study from the University of Illinois.

Cannabis Use May Increase Risk of Preterm Birth

Teenagers who use cannabis frequently may be more likely to have children born preterm, when they become parents up to twenty years later, finds a new study.

Oil Palm Development Threatens African and Latin American Biodiversity, New Reports Warns

New research suggests that zero deforestation pledges may leave important habitats, biodiversity in Latin America and Africa vulnerable to agricultural growth.